Anjidani N, Shahpari R, Kafi H, Petrovsky N, Barati S
Sci Rep. 2024; 14(1):22631.
PMID: 39349494
PMC: 11442574.
DOI: 10.1038/s41598-024-67945-3.
Gromer D, Plikaytis B, McCullough M, Wimalasena S, Rouphael N
Vaccines (Basel). 2024; 12(7).
PMID: 39066447
PMC: 11281354.
DOI: 10.3390/vaccines12070809.
Saez-Penataro J, Calvo G, Bascuas J, Mosquera M, Marcos M, Egri N
Vaccines (Basel). 2024; 12(6).
PMID: 38932394
PMC: 11209257.
DOI: 10.3390/vaccines12060665.
Ciccimarra F, Luxi N, Bellitto C, LAbbate L, Raethke M, van Hunsel F
Vaccines (Basel). 2024; 12(3).
PMID: 38543875
PMC: 10974422.
DOI: 10.3390/vaccines12030241.
Mochida Y, Uchida S
RNA Biol. 2024; 21(1):1-27.
PMID: 38528828
PMC: 10968337.
DOI: 10.1080/15476286.2024.2333123.
Factors influencing adverse events following COVID-19 vaccination.
Villanueva P, McDonald E, Croda J, Croda M, Dalcolmo M, Dos Santos G
Hum Vaccin Immunother. 2024; 20(1):2323853.
PMID: 38445666
PMC: 10936640.
DOI: 10.1080/21645515.2024.2323853.
Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination.
Ziegler L, Klemis V, Schmidt T, Schneitler S, Baum C, Neumann J
EBioMedicine. 2023; 95:104743.
PMID: 37574375
PMC: 10505826.
DOI: 10.1016/j.ebiom.2023.104743.
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects.
Brisotto G, Montico M, Turetta M, Zanussi S, Cozzi M, Vettori R
Viruses. 2023; 15(6).
PMID: 37376576
PMC: 10305214.
DOI: 10.3390/v15061276.
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE).
Bannister W, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B
Open Forum Infect Dis. 2023; 10(6):ofad248.
PMID: 37351453
PMC: 10284342.
DOI: 10.1093/ofid/ofad248.
Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions.
Klingel H, Kruttgen A, Imohl M, Kleines M
Clin Exp Vaccine Res. 2023; 12(1):60-69.
PMID: 36844685
PMC: 9950231.
DOI: 10.7774/cevr.2023.12.1.60.
Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID-19 Vaccination Antibody Response.
Petri M, Joyce D, Haag K, Fava A, Goldman D, Zhong D
Arthritis Care Res (Hoboken). 2023; 75(9):1878-1885.
PMID: 36714913
PMC: 10387122.
DOI: 10.1002/acr.25094.
Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study.
Choi M, Heo J, Seo Y, Yoon Y, Sohn J, Noh J
Vaccines (Basel). 2023; 11(1).
PMID: 36679965
PMC: 9862064.
DOI: 10.3390/vaccines11010120.
SARS-CoV-2-The Role of Natural Immunity: A Narrative Review.
Diani S, Leonardi E, Cavezzi A, Ferrari S, Iacono O, Limoli A
J Clin Med. 2022; 11(21).
PMID: 36362500
PMC: 9655392.
DOI: 10.3390/jcm11216272.
Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study.
Hermann E, Lee B, Balte P, Xanthakis V, Kirkpatrick B, Cushman M
JAMA Netw Open. 2022; 5(10):e2237908.
PMID: 36269359
PMC: 9587476.
DOI: 10.1001/jamanetworkopen.2022.37908.
Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic Medication.
Tani N, Ikematsu H, Goto T, Gondo K, Inoue T, Yanagihara Y
Open Forum Infect Dis. 2022; 9(10):ofac493.
PMID: 36267253
PMC: 9578158.
DOI: 10.1093/ofid/ofac493.
Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assay.
Wakui M, Uwamino Y, Yatabe Y, Nakagawa T, Sakai A, Kurafuji T
Eur J Immunol. 2022; 52(12):1961-1971.
PMID: 36250411
PMC: 9874394.
DOI: 10.1002/eji.202249794.
Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers.
Brunner W, Freilich D, Victory J, Krupa N, Scribani M, Jenkins P
Int J Infect Dis. 2022; 123:183-191.
PMID: 36044963
PMC: 9420538.
DOI: 10.1016/j.ijid.2022.08.022.
Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.
Kurashima K, Numano T, Yoshino A, Osawa A, Takaku Y, Kagiyama N
Vaccine. 2022; 40(39):5670-5674.
PMID: 36030124
PMC: 9393162.
DOI: 10.1016/j.vaccine.2022.08.035.
Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses.
Nam M, Yun S, Kim S, Kim C, Cha J, Lee C
Microbiol Spectr. 2022; 10(4):e0249521.
PMID: 35946811
PMC: 9431224.
DOI: 10.1128/spectrum.02495-21.
Twelve-Month Longitudinal Serology in SARS-CoV-2 Naïve and Experienced Vaccine Recipients and Unvaccinated COVID-19-Infected Individuals.
Congrave-Wilson Z, Cheng W, Lee Y, Perez S, Turner L, Marentes Ruiz C
Vaccines (Basel). 2022; 10(5).
PMID: 35632569
PMC: 9143304.
DOI: 10.3390/vaccines10050813.
